Clinical Trial Update: A Multicenter, Placebo-controlled, Double-blind Investigative Extension Trial of the Safety and Efficacy of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode [Phase 3]

View source ↗

Summary

A Phase 3 multicenter, placebo-controlled extension study evaluated the safety and efficacy of aripiprazole in bipolar I disorder patients experiencing manic or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Bipolar I Disorder | Phase 3 | Status: COMPLETED | Results posted: 2014-02-12